Terumo (TSE:4543) Gross-Profit-to-Asset % : 28.23% (As of Mar. 2024)

View and export this data going back to 1982. Start your Free Trial

What is Terumo Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Terumo's annualized Gross Profit for the quarter that ended in Mar. 2024 was 円497,336 Mil. Terumo's average Total Assets over the quarter that ended in Mar. 2024 was 円1,761,535 Mil. Therefore, Terumo's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 28.23%.

Terumo Gross-Profit-to-Asset % Historical Data

The historical data trend for Terumo's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terumo Gross-Profit-to-Asset % Chart

Terumo Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

29.12

25.20

26.15

27.14

27.91

Terumo Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															25.18	26.84	27.72	29.44	28.23

Competitive Comparison of Terumo's Gross-Profit-to-Asset %

For the Medical Instruments & Supplies subindustry, Terumo's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Terumo's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Terumo's Gross-Profit-to-Asset % falls into.

Terumo Gross-Profit-to-Asset % Calculation

Terumo's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Mar. 2024 )	/	( (Total Assets (A: Mar. 2023 )	+	Total Assets (A: Mar. 2024 ))	/ count )
	=	479174	/	( (1602225	+	1831402)	/ 2 )
	=	479174	/	1716813.5
	=	27.91 %

Terumo's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	497336	/	( (1691667	+	1831402)	/ 2 )
	=	497336	/	1761534.5
	=	28.23 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Terumo Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Terumo's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Terumo (TSE:4543) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (TSE:4543) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

TRUMY:USA TRUMF:USA TUO:Germany

Address

2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072

Website

https://www.terumo.com

Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.

Terumo (TSE:4543) Headlines

No Headlines